SARS-CoV-2 B.1.1.7, also called the UK variant. The green depicts viral DsRNA and red shows viral nucleocapsid protein – these are both viral biomarkers, and indicate that the cell shown is infected by SARS-CoV-2. Credit: Dr. Guang Gao, UBC LSI IMAGING

Canadian researchers lead development and testing of promising treatment for COVID-19 variants

Posted on

A new anti-viral drug could improve COVID-19 outcomes and survival rates — and is highly effective against multiple variants — according to a new study led by researchers at the University of British Columbia and Université de Sherbrooke.

The drug, called N-0385, blocks the SARS-CoV-2 virus from entering human cells through its favoured cell gateways. The results of the study are under review for publication in a scientific journal and have been uploaded as a preprint….

https://news.ubc.ca/2021/05/11/canadian-researchers-lead-development-and-testing-of-promising-treatment-for-covid-19-variants/

Read More Impact Stories

Posted on
This article is only available in French. Lésion de la moelle épinière: stimuler la plasticité des neurones pour améliorer la [...]
Posted on
A comprehensive study by scientists at UdeM maps the evolutionary dynamics and risks of viral emergence of diseases that could [...]
Posted on
This article is available only in French. Infections respiratoires: mieux trier les patients pour soulager la pression sur les urgences [...]